TCL Archive Cancer Advocacy: Deal Returns $3M to Office of Women’s Health, Spends $3.5M On Workshops August 1, 1997
TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012
TCL Archive Release of Mayo Pathology Report Would Be Needed To Confirm Stage IIA Diagnosis. October 24, 2008
TCL Archive Study: Prostate Cancer Classifier Can Predict Risk Better Than PSA, Gleason Score, Tumor Stage February 28, 2014
